Please Wait
Applying Filters...
menu
    • menu
    Global API micronization market set to surge 49% by 2030, led by specialized industry pioneers

    Data Compilation
    #PharmaFlow

    Pipeline Prospector September 2025: Genmab buys Merus for ~US$ 8 billion, Pfizer buys Metsera to enter obesity race

    Stock Recap
    #PipelineProspector

    Menu

    Lasix;Frusemide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 47Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    19/09/2025 Ipca Laboratories
    India
    		 M/s IPCA Laboratories Ltd WC-0091 Furosemide BP/Ph.Eur./JP/USP 2025-06-19 2028-07-02 P.O. Sejavta, District -Ratlam, (M.P.)-457001, India
    04/06/2025 Mangalam Drugs & Organics Ltd
    India
    		 M/s Mangalam Drugs and Organics Ltd WC-0473 Furosemide IH/BP/IP/USP/EP 2024-03-21 2027-03-20 Unit-2, Plot No 1203, Ill Phase GIDC, Vapi -396195, Dist.-Valsad, Gujarat, India